Sponsor Pipeline

Kymera Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
3
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07323654 A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe… Eosinophilic Asthma Recruiting
NCT07677059 A Long-term Study of KT-621 Administered Orally to Participants With Asthma Previously… Asthma (Diagnosis) Recruiting
NCT07217015 A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic… Atopic Dermatitis Active, Not Recruiting
Phase 1
NCT07412288 First-in-human Study of Orally Administered KT-579 in Healthy Adult Participants Healthy Participants Recruiting
Disease Areas
Get alerts when Kymera Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free